LXRX icon

Lexicon Pharmaceuticals
LXRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$4.15
122% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citigroup
Citigroup
Yigal Nochomovitz
50% 1-yr LXRX win rate
10 Mar ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Joseph Pantginis
100% 1-yr LXRX win rate
5 Mar ‘26 1 month ago